Literature DB >> 5671570

[On malignancy diagnosis using the oxytetracycline-fluorescence test].

H Schubert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5671570

Source DB:  PubMed          Journal:  Arch Klin Exp Dermatol        ISSN: 0300-8614


× No keyword cloud information.
  51 in total

1.  FLUORESCENT TEST FOR SKIN MALIGNANCY.

Authors:  D BURROWS
Journal:  Arch Dermatol       Date:  1964-10

2.  PHOTO-IRRADIATION STUDIES OF TWO TETRACYCLINES. TETRACYCLINE AND DEMETHYLCHLORTETRACYCLINE.

Authors:  W F SCHORR; S MONASH
Journal:  Arch Dermatol       Date:  1963-10

3.  FACTORS AFFECTING THE SITE AND DEGREE OF LOCALIZATION OF TETRACYCLINE IN SARCOMA 37 TUMORS.

Authors:  L MACHADO; I ZAIDMAN; J F GERSTEIN; F LICHTENBERG; S J GRAY
Journal:  Cancer Res       Date:  1964-11       Impact factor: 12.701

4.  [TETRACYCLINE AND HISTO- AND CYTOPATHOLOGY OF THE SKIN].

Authors:  L POPOFF; S GEORGIEWA
Journal:  Hautarzt       Date:  1965-02       Impact factor: 0.751

5.  [CANCER DIAGNOSIS BY CYTOLOGICAL STUDIES IN COMBINATION WITH THE TETRACYCLINE FLUORESCENCE TEST].

Authors:  F JUMMEL
Journal:  Munch Med Wochenschr       Date:  1964-11-13

6.  New aspects of tetracycline analogues distribution and fixing in pathologically changed tissue.

Authors:  P MALEK; J KOLC; F ZAK; V ZASTAVA
Journal:  Chemotherapia (Basel)       Date:  1962

7.  Detection by fluorescence of oxytetracycline bound to bone.

Authors:  E MUZII
Journal:  Nature       Date:  1961-03-18       Impact factor: 49.962

8.  [Fluorescence microscopy in the study of haversian changes].

Authors:  J P GHOSEZ
Journal:  Arch Biol (Liege)       Date:  1959 Apr-Jun

9.  On the distribution of tetracycline in the body.

Authors:  L E BOTTIGER
Journal:  Antibiot Chemother (Northfield)       Date:  1955-06

10.  The use of tetracycline fluorescence to identify necrosis of renal tubules and to assess renal blood flow.

Authors:  E Tapp; R Carroll; K Kovács
Journal:  Experientia       Date:  1964-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.